Related Experiment Video

Updated: Oct 6, 2025

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
09:29

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

Published on: July 14, 2023

937

The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases

Grażyna Sygitowicz1, Agata Maciejak-Jastrzębska1, Dariusz Sitkiewicz1

  • 1Department of Clinical Chemistry and Laboratory Diagnostics, Medical University of Warsaw, 02-097 Warsaw, Poland.

Biomolecules
|January 21, 2022
PubMed

Insights

Galectin-3 is a key protein in chronic inflammation and heart disease. Elevated levels indicate heart failure and aid in diagnosing cardiovascular conditions.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Inflammation Studies

Background:

  • Galectin-3 is implicated in chronic inflammation and various diseases, notably heart disease.
  • This regulatory protein elevates in acute and chronic heart failure, contributing to myocardial remodeling post-injury.

Purpose of the Study:

  • To explore galectin-3's potential as a diagnostic and prognostic biomarker.
  • To review its role in cardiovascular and cerebrovascular diseases.

Main Methods:

  • Literature review and analysis of galectin-3's role in disease pathogenesis.
  • Examination of its utility in acute ischemic stroke, acute coronary syndromes, heart failure, and arrhythmogenic cardiomyopathy.

Main Results:

  • Galectin-3 is elevated in heart failure, indicating its involvement in inflammatory pathways.
  • Its role in myocardial fibrosis and inflammation is increasingly understood.
  • Potential as a biomarker for disease severity and prognosis is highlighted.

Conclusions:

  • Galectin-3 shows promise as a diagnostic and prognostic biomarker for cardiovascular diseases.
  • It is a significant factor in myocardial fibrosis and inflammation.
  • Galectin-3 is a potential therapeutic target for heart failure and myocardial infarction.

Keywords:
MMPsatrial fibrillationcardiac fibrosischronic inflammationgalectin-3heart failurelncRNAsmicroRNAs

More Related Videos

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

854
Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads08:48

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads

Published on: December 9, 2020

2.3K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
84
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40